THC — Tenet Healthcare Corporation

Tenet Healthcare Corporation (THC) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Net Operating Revenues: $21.3 billion for the full year 2025.
• Consolidated Adjusted EBITDA: $4.57 billion, a 14% increase from 2024, with a margin of 21.4%, up 210 basis points year-over-year.
• Q4 Results:
  • Net Operating Revenues: $5.5 billion.
  • Adjusted EBITDA: $1.183 billion, a 13% increase year-over-year.
  • Adjusted EBITDA margin: 21.4%.
• USPI Segment: Adjusted EBITDA grew 12% to $2.026 billion, with same-facility revenues up 7.5%.
• Free Cash Flow: $367 million in Q4 and $2.53 billion for the full year.
• Share Repurchases: Approximately 22% of outstanding shares repurchased since 2022 for around $2.5 billion.

2. Strategic Updates and Business Highlights

• M&A Activity: Invested nearly $350 million in 2025, adding 35 facilities, with a strong pipeline for future growth.
• Hospital Segment: Adjusted EBITDA increased 16% to $2.54 billion, with same-store revenues per adjusted admission up 5.3%.
• Operational Improvements: Focus on high acuity services and disciplined cost control contributed to strong performance.
• Technology Investments: Emphasis on structural expense management through technology and automation to enhance efficiency.

3. Forward Guidance and Outlook

• 2026 Adjusted EBITDA Guidance: Projected between $4.485 billion and $4.785 billion, driven by demand strength and service line expansion.
• USPI EBITDA Guidance: Expected between $2.13 billion and $2.23 billion.
• Hospital Segment EBITDA Guidance: Anticipated between $2.355 billion and $2.555 billion, factoring in headwinds from the expiration of enhanced premium tax credits.
• Revenue Growth: Consolidated net operating revenues projected between $21.5 billion and $22.3 billion for 2026.

4. Bad News, Challenges, or Points of Concern

• Enrollment Decline: Anticipated 20% reduction in overall enrollment due to the expiration of enhanced premium tax credits, particularly affecting states with significant exposure.
• Hospital Volume Growth: Projected growth of 1% to 2% in 2026, slower than previous years, influenced by the expiration of tax credits and overall market conditions.
• Uncertainty in Payer Mix: Potential increase in uninsured rates and challenges in maintaining favorable payer mix as patients transition from exchange plans.
• Operational Risks: Need for continued focus on cost management and efficiency improvements amid a changing healthcare landscape.

5. Notable Q&A Insights

• Hospital Volume Performance: Q4 same-store hospital admissions were flat, attributed to a weaker respiratory season.
• Expense Management Strategy: Focus on structural changes rather than traditional annual cost-cutting, leveraging technology for sustainable efficiencies.
• Impact of Exchange Programs: Management acknowledged uncertainty regarding the effect of enrollment changes on future volumes and revenues.
• Conifer Transaction: The recent Conifer deal was framed as a strategic move to enhance future growth and control, with significant financial benefits anticipated.
• USPI Growth Opportunities: Continued focus on higher acuity procedures and expansion into new service lines, particularly in response to changes in inpatient-only lists.

This summary encapsulates Tenet Healthcare's financial performance, strategic direction, and outlook while highlighting potential challenges and insights from the earnings call.